11/21
07:30 am
incy
INCY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Incyte Corporation investment
Low
Report
INCY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Incyte Corporation investment
11/21
12:17 am
incy
Incyte Co. (NASDAQ: INCY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Incyte Co. (NASDAQ: INCY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
11/21
12:17 am
incy
Incyte Co. (NASDAQ: INCY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Incyte Co. (NASDAQ: INCY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
11/19
04:30 pm
incy
Lost Money on Incyte Corporation(INCY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Low
Report
Lost Money on Incyte Corporation(INCY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
11/19
03:58 pm
incy
Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study [Yahoo! Finance]
Low
Report
Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study [Yahoo! Finance]
11/19
01:30 pm
incy
Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study [Yahoo! Finance]
Medium
Report
Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study [Yahoo! Finance]
11/19
11:00 am
incy
Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered. [Yahoo! Finance]
Medium
Report
Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered. [Yahoo! Finance]
11/19
09:31 am
incy
Incyte Co. (NASDAQ: INCY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Incyte Co. (NASDAQ: INCY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
11/18
04:34 pm
incy
Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs [Yahoo! Finance]
Medium
Report
Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs [Yahoo! Finance]
11/18
04:30 pm
incy
Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
Medium
Report
Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
11/14
12:07 pm
incy
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Royal Bank of Canada from $72.00 to $80.00. They now have a "sector perform" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Royal Bank of Canada from $72.00 to $80.00. They now have a "sector perform" rating on the stock.
11/14
08:00 am
incy
Incyte to Present at Upcoming Investor Conference
Medium
Report
Incyte to Present at Upcoming Investor Conference
11/7
04:30 pm
incy
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/7
09:59 am
incy
Graft Versus Host Disease (GvHD) Treatment Industry Forecast Report, 2024-2032 - Global Market Size Forecast to Double, with Emerging Markets Offering Substantial Growth Potential [Yahoo! Finance]
Low
Report
Graft Versus Host Disease (GvHD) Treatment Industry Forecast Report, 2024-2032 - Global Market Size Forecast to Double, with Emerging Markets Offering Substantial Growth Potential [Yahoo! Finance]
11/6
06:05 am
incy
Bank of America Turns Bullish on These 2 Lesser-Known Stocks [Yahoo! Finance]
Medium
Report
Bank of America Turns Bullish on These 2 Lesser-Known Stocks [Yahoo! Finance]
11/6
02:33 am
incy
Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Developments [Yahoo! Finance]
Medium
Report
Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Developments [Yahoo! Finance]
11/4
01:44 pm
incy
BMRN vs. INCY: Which Stock Is the Better Value Option? [Yahoo! Finance]
Low
Report
BMRN vs. INCY: Which Stock Is the Better Value Option? [Yahoo! Finance]
10/31
11:05 pm
incy
Incyte Co. (NASDAQ: INCY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Incyte Co. (NASDAQ: INCY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
10/30
04:43 pm
incy
Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock [Yahoo! Finance]
Low
Report
Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock [Yahoo! Finance]
10/30
03:35 pm
incy
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Citigroup Inc. from $92.00 to $97.00. They now have a "buy" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Citigroup Inc. from $92.00 to $97.00. They now have a "buy" rating on the stock.
10/30
03:35 pm
incy
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Wells Fargo & Company from $62.00 to $68.00. They now have an "equal weight" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Wells Fargo & Company from $62.00 to $68.00. They now have an "equal weight" rating on the stock.
10/30
02:19 pm
incy
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $63.00 to $70.00. They now have a "neutral" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $63.00 to $70.00. They now have a "neutral" rating on the stock.
10/30
02:16 pm
incy
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Morgan Stanley from $64.00 to $69.00. They now have an "equal weight" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Morgan Stanley from $64.00 to $69.00. They now have an "equal weight" rating on the stock.
10/30
01:03 pm
incy
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Royal Bank of Canada from $67.00 to $72.00. They now have a "sector perform" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at Royal Bank of Canada from $67.00 to $72.00. They now have a "sector perform" rating on the stock.
10/30
12:21 pm
incy
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at JPMorgan Chase & Co. from $65.00 to $71.00. They now have a "neutral" rating on the stock.
Low
Report
Incyte Co. (NASDAQ: INCY) had its price target raised by analysts at JPMorgan Chase & Co. from $65.00 to $71.00. They now have a "neutral" rating on the stock.